<DOC>
	<DOCNO>NCT02038179</DOCNO>
	<brief_summary>We propose novel intervention reduce BP could preferential impact patient hyperuricemia gout . There great need new anti-hypertensives , particularly among gout . The propose study novel plan investigate physiologic mechanism urate contributes vascular disease ULT may contribute BP reduction . Also innovative , : 1 ) determine extent describe benefit lowering serum urate extend beyond adolescent population previously study young adult , 2 ) test whether urate-lowering approach benefit individual yet meet current definition hyperuricemia gout , 3 ) begin explore potential mechanism high prevalence hypertension among African-Americans . If successful , work could translate standard clinical care health care recommendation population whole .</brief_summary>
	<brief_title>UAB Center Research Translation ( CORT ) Project 2 : The Effects Urate Lowing Therapy ( ULT ) Inflammation , Endothelial Function , Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Prehypertension</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>Prehypertension stage I hypertension , define follow mean two clinic measurement : Systolic blood pressure ( SBP ) ≥ 120 &lt; 160 ; Diastolic blood pressure ( DBP ) ≥ 80 &lt; 100 Serum urate ≥ 5.0 mg/dL men ≥ 4.0 mg/dL woman Age 1840 Any current pharmacological treatment hypertension , include diuretic Estimated glomerular filtration rate &lt; 60 mL/min/1.73m2 Current use uratelowering therapy statin Prior diagnosis gout past use uratelowering therapy gout Prior diagnosis diabetes Pregnancy , recent delivery last trim pregnancy loss recent 3 month Active smoker Immunesuppressed individual include transplant recipient current use azathioprine . Leucopenia absolute white cell count &lt; 3000 /mL , anemia hemoglobin &lt; 12 g/dL , thrombocytopenia platelet count &lt; 150,000/mL Individuals Han Chinese Thai descent HLAB5801 genetic phenotype Serious medical condition investigator 's judgment preclude utilization fix dose allopurinol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Pre-hypertension</keyword>
	<keyword>JNC 7 stage I hypertension</keyword>
</DOC>